Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Hydroxyacyl-CoA Dehydrogenase (HADH) Peptide

HADH Host: Synthetic BP, WB, IHC
Catalog No. ABIN8102853
$145.08
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Hydroxyacyl-CoA Dehydrogenase (HADH) Peptide (ABIN8102853)

Target

HADH (Hydroxyacyl-CoA Dehydrogenase (HADH))

Source

  • 7
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Purpose

    HADH Peptide
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    This is a synthetic peptide designed for use in combination with anti-HADH antibody ( ARP54765_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    HADH (Hydroxyacyl-CoA Dehydrogenase (HADH))

    Background

    Background Information: HADH functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alternative Symbols: HAD, HADH1, HADHSC, HHF4, M/SCHAD, MGC8392, SCHAD, HCDH, MSCHAD

    Molecular Weight

    33kDa

    Gene ID

    3033

    NCBI Accession

    NP_005318

    UniProt

    Q16836
You are here:
Chat with us!